000 02796 a2200361 4500
001 1040300227
005 20250328151431.0
008 250324022025xx 118 eng
020 _a9781040300220
_qEA
037 _bTaylor & Francis
_cGBP 49.99
_fBB
040 _a01
041 _aeng
072 7 _aPSD
_2thema
072 7 _aMJCJ
_2thema
072 7 _aMJCM
_2thema
072 7 _aMBNS
_2thema
072 7 _aPSD
_2bic
072 7 _aMJCJ
_2bic
072 7 _aMJCM
_2bic
072 7 _aMBNS
_2bic
072 7 _aSCI045000
_2bisac
072 7 _aMED044000
_2bisac
072 7 _aMED078000
_2bisac
072 7 _aMED022090
_2bisac
072 7 _a616.9364
_2bisac
100 1 _aVeer Singh
245 1 0 _aVisceral Leishmaniasis and Post-kala-azar Dermal Leishmaniasis
_bPathogenesis, Treatment and Disease Control
250 _a1
260 _bCRC Press
_c20250403
300 _a240 p
520 _bThis reference book explores various aspects of visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL), including their pathophysiology, treatment options, and disease control strategies. The initial chapter provides an overview of VL, its global impact, and pathogenesis. It also examines the development of PKDL from VL, outlining the transition from the acute form of the disease to the chronic dermal condition. The book further explores the symptoms and diagnosis of both VL and PKDL. Furthermore, the book delves into the immunopathogenesis of both VL and PKDL, shedding light on the complex interactions between the parasite and the host immune system. It reviews the impact of environmental factors, particularly the contamination of arsenic and antimony in drinking water, on the progression of the disease. Lastly, the book discusses preventive measures for PKDL and highlights the major challenges in effectively implementing these strategies. This book serves as a useful resource for researchers, healthcare professionals, and policymakers seeking to deepen their understanding of these diseases and develop effective strategies for their prevention and control. Key features Provides in-depth coverage of VL and PKDL, including pathogenesis, treatment, and disease control strategies Elucidates the symptoms and diagnostic methods for VL and PKDL Offers insights into the complex immunopathogenesis of VL and PKDL, exploring the interactions between parasites and host immune system Examines treatment options for both VL and PKDL, including current therapeutic approaches and emerging strategies Reviews the impact of environmental factors, such as arsenic and antimony contamination, on the disease progression Discusses preventive measures and challenges in implementing effective strategies for PKDL prevention and control
700 1 _aAshish Kumar
_4B01
999 _c8911
_d8911